Clinical Trial: 1-Week Versus 3-Week PBI

U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07832279) titled '1-Week Versus 3-Week PBI' on Sept. 16.

Brief Summary: This non-inferiority, phase 3 clinical trial evaluates the cosmetic non-inferiority of a one-week regimen (26 Gy/5 Fx) versus a three-week regimen (40 Gy/15 Fx) using intensity-modulated radiation therapy (IMRT) for partial breast irradiation (PBI) in low-risk breast cancer patients post-breast-conserving surgery.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Early-Stage Breast Cancer

Intervention: RADIATION: 3-week PBI

40.05Gy/15Fx/3w, 2.67Gy/Fx, once daily

RADIATION: 1-week PBI

26Gy/5Fx/1w, 5.2Gy/Fx, once daily

Recruitment Status: RECRUITING

Spo...